Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients.
Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients.
复制标题
DOI:
10.1371/journal.pone.0038150
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Liu ZQ
中科院分区:
文献类型:
--
作者:
Yin JY;Huang Q;Zhao YC;Zhou HH;Liu ZQ
To determine the pharmacogenetics of platinum-based chemotherapy in Non Small Cell Lung Cancer (NSCLC) patients. Publications were selected from PubMed, Cochrane Library and ISI Web of Knowledge. A meta-analysis was conducted to determine the association between genetic polymorphisms and platinum-based chemotherapy by checking odds ratio (OR) and 95% confidence interval (CI). Data were extracted from 24 publications, which included 11 polymorphisms in 8 genes for meta-analysis. MDR1 C3435T (OR = 1.97, 95% CI: 1.11–3.50, P = 0.02), G2677A/T (OR = 2.61, 95% CI: 1.44–4.74, P = 0.002) and GSTP1 A313G (OR = 0.32, 95% CI: 0.17–0.58, P = 0.0002) were significantly correlated with platinum-based chemotherapy in Asian NSCLC patients. Attention should be paid to MDR1 C3435T, G2677A/T and GSTP1 A313G for personalized chemotherapy treatment for NSCLC patients in Asian population in the future.
登录
查看更多内容
影响因子:
2.2
作者:
DerSimonian, Rebecca;Kacker, Raghu
通讯作者:
Kacker, Raghu
影响因子:
3.7
作者:
Feng, Jifeng;Sun, Xinchen;Zhou, Yingfeng
通讯作者:
Zhou, Yingfeng
DOI:
10.1016/0197-2456(86)90046-2
发表时间:
1986-09-01
期刊:
CONTROLLED CLINICAL TRIALS
影响因子:
--
作者:
DERSIMONIAN, R;LAIRD, N
通讯作者:
LAIRD, N
影响因子:
20.4
作者:
Booten, Richard;Ward, Tim;Thatcher, Nicholas
通讯作者:
Thatcher, Nicholas
影响因子:
9.8
作者:
Huang, R. Stephanie;Duan, Shiwei;Dolan, M. Eileen
通讯作者:
Dolan, M. Eileen